DiaCarta provides a high-throughput COVID-19 testing service for the reopening of businesses & schools. We also provide onsite sample collection for PCR (NAAT) test and IgM Test. Managed by the LIMS (Laboratory Information Management System), the whole clinical laboratory workflow is seamless from sample to report. The DiaCarta Clinical Laboratory is Clinical Laboratory Improvement Amendments (CLIA) certified and qualified for performing high complexity testing. Our test has been approved by the US FDA under an Emergency Use Authorization (EUA) and was validated in accordance with the FDA Guidance Document Policy.